Submitted by Anonymous (not verified) on 18 May 2026 - 15:05
Human medicines European public assessment report (EPAR): Imfinzi, durvalumab, Date of authorisation: 21/09/2018, Revision: 28, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Imfinzi, durvalumab, Date of authorisation: 21/09/2018, Revision: 28, Status: Authorised